Shopping Cart
- Remove All
- Your shopping cart is currently empty
Bersacapavir (JNJ-56136379) is a novel in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Bersacapavir is metabolized by cytochrome P450 (CYP) 3A and can be used to study Bersacapavir infection.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $954 | In Stock | |
50 mg | $1,240 | In Stock | |
100 mg | $1,990 | In Stock |
Description | Bersacapavir (JNJ-56136379) is a novel in vitro modulator of hepatitis B virus capsid assembly that inhibits HBV replication.Bersacapavir is metabolized by cytochrome P450 (CYP) 3A and can be used to study Bersacapavir infection. |
Alias | JNJ-6379, JNJ6379, JNJ-56136379, JNJ56136379, JNJ-379, JNJ379 |
Molecular Weight | 418.37 |
Formula | C16H14F4N4O3S |
Cas No. | 1638266-40-6 |
Smiles | C(NC1=CC(C#N)=C(F)C=C1)(=O)C2=CC(S(N[C@H](C(F)(F)F)C)(=O)=O)=CN2C |
Storage | keep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 80 mg/mL (191.22 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.